AN2 Therapeutics
ANTX
#8920
Rank
โ‚ฌ0.17 B
Marketcap
4,63ย โ‚ฌ
Share price
-2.68%
Change (1 day)
389.30%
Change (1 year)

Earnings for AN2 Therapeutics (ANTX)

Earnings in 2026 (TTM): -โ‚ฌ33.41 Million

According to AN2 Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ34.75 Million, an increase over its 2024 earnings that were of -โ‚ฌ49.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AN2 Therapeutics from 2021 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ33.41 Million-3.85%
2025 -โ‚ฌ34.75 Million-30.14%
2024 -โ‚ฌ49.74 Million-21.66%
2023 -โ‚ฌ63.48 Million64.77%
2022 -โ‚ฌ38.53 Million95.89%
2021 -โ‚ฌ19.67 Million